ARCH Venture declares 12.9% of Aspen Neuroscience, held for investment
ARCH Venture Fund X and its affiliated funds hold 12.9% of Aspen Neuroscience after its IPO and say they hold the shares for investment, with no present plans.
The filing
13D
12.9%
Of the shares
$48.96M
Value
Active
Investor
A
Aspen Neuroscience, Inc. Common Stock
Holds 3,754,922 shares
Stated purpose
ARCH Venture says it acquired Aspen Neuroscience shares for investment, may buy or sell more depending on market conditions, and has no present plans for other actions listed in Item 4.
Declared to the SEC, the US stock market watchdog (Schedule 13D), after the 5% threshold was crossed on November 2, filed on November 9.
AI analysis
Nov 9
With TrueWallet Pro
What this filing changes for the stock, what the fund wants, and what it does not say. Upgrade to Pro from the TrueWallet app.